Skip to main content

RITE AID

  • Ken Martindale departs Rite Aid, company names new COO

    CAMP HILL, Pa. — Rite Aid has announced that president of Rite Aid and CEO of Rite Aid stores Ken Martindale, will leave the company, effective immediately, to assume his new role at the helm of GNC as CEO. Rite Aid also announced it has promoted Bryan Everett, currently EVP in charge of store operations, to the newly created position of COO Rite Aid stores. 

  • J.D. Power pharmacy rankings take downturn on negative Rx price perception

    COSTA MESA, Calif. — The U.S. pharmacy industry, perennially one of the highest-scoring industries measured by J.D. Power, experienced notable declines in overall customer satisfaction this year, the research firm reported Tuesday. According to the J.D. Power 2017 U.S. Pharmacy Study, decreases in satisfaction with both brick-and-mortar and mail order pharmacies were driven primarily by declines in satisfaction with cost.

  • All but one Houston-area RediClinics have reopened following Harvey's exit

    HOUSTON — As of Saturday, RediClinic has reopened 21 of its 22 clinics in Houston and the surrounding area. The clinics are operating on a modified schedule from 9 a.m-6 p.m.

  • Retail pharmacy focuses support on Gulf Coast region

    HOUSTON — One week following Hurricane Harvey, the Gulf region where that powerful storm made landfall is beginning to put the pieces back together. For example, Walmart, among other retailers have reported the reopening of all stores with the exception of a handful of locations impacted by flooding.

  • Rite Aid Foundation launches KidCents Safe Medication Disposal Program

    CAMP HILL, Pa. — The Rite Aid Foundation announced Wednesday the rollout of its KidCents Safe Medication Disposal Program, a new program focused on reducing drug accessibility, medication misuse and accidental poisoning among children and adolescents.

  • Antitrust suit involving generic Lipitor, Effexor XR back on

    A United States appeals court has revived an antitrust lawsuit against four drug makers, alleging that they hamstrung generics for Lipitor and Effexor XR.

    The plaintiffs, a coalition of labor unions and retailers, including Rite Aid and Walgreens, accused four drug makers of reverse settlement payment deals, in which a drug’s patent holder pays the accused infringer not to produce the patented item. The plaintiffs allege Ranbaxy accepted such payments from Pfizer to delay generics for Lipitor, while Wyeth accepted payments from Teva to delay Effexor XR.

  • Rite Aid to leverage RangeMe tech platform for product sourcing

    SAN FRANCISCO — Rite Aid plans to leverage RangeMe, an online platform that streamlines new product discovery between suppliers and retailers, to scale its product innovation efforts.

    “We strive to provide a tremendous in-store experience for our customers and that starts with our product offerings,” said Bill Bergin, Group VP of health and beauty at Rite Aid. “With RangeMe, we can now scale our discovery efforts and continue to source products that are unique and meaningful for our customers.”

  • WBA and Rite Aid withdraw deal for 2,000-plus stores, to refile Friday

    DEERFIELD, Ill. — Walgreens Boots Alliance and Rite Aid on Wednesday filed notice with the Securities and Exchange Commission that the companies would be withdrawing its initial deal to acquire 2,186 Rite Aid stores, and will refile that agreement by Friday, August 18.

    That will reset the clock on the waiting period under the HSR Act with to Sept. 18, 2017, unless otherwise extended or terminated.

X
This ad will auto-close in 10 seconds